Anti-inflammatory agent
US5872109A · kind A · utility
22Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 1996 |
| Grant date | Feb 16, 1999 |
| Priority date | — |
| Expiry date | Oct 4, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/737
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of a polysaccharide selected from the group consisting of sulfated acid mucopolysaccharides and sulfated dextrans, and physiologically acceptable salts thereof for prophylaxis or treatment of inflammations, particularly an adult respiratory distress syndrome (ARDS), ischemic heart diseases, ischemic cerebral diseases, chronic articular rheumatism, atopic dermatitis, and infiltration after organ implantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.